226 related articles for article (PubMed ID: 36239935)
21. 'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome.
van der Pool AE; Lalmahomed ZS; Ozbay Y; de Wilt JH; Eggermont AM; Jzermans JN; Verhoef C
Colorectal Dis; 2010 Oct; 12(10 Online):e229-35. PubMed ID: 19912286
[TBL] [Abstract][Full Text] [Related]
22. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and management of liver metastases from colorectal cancer.
Manfredi S; Lepage C; Hatem C; Coatmeur O; Faivre J; Bouvier AM
Ann Surg; 2006 Aug; 244(2):254-9. PubMed ID: 16858188
[TBL] [Abstract][Full Text] [Related]
24. A preliminary analysis of combined liver resection with new chemotherapy for synchronous and metachronous colorectal liver metastasis.
Ng WW; Cheung YS; Wong J; Lee KF; Lai PB
Asian J Surg; 2009 Oct; 32(4):189-97. PubMed ID: 19892621
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of synchronous and metachronous duodenal tumors and association with colorectal cancer: a supplementary analysis.
Yamasaki Y; Kato M; Takeuchi Y; Hoteya S; Oyama T; Nonaka S; Yoshimizu S; Yoshida M; Ohata K; Miura Y; Hara Y; Tsuji S; Dohi O; Ueyama H; Kurahara K; Tashima T; Abe N; Mitsuhashi T; Nakayama A; Oda I; Yahagi N
J Gastroenterol; 2023 May; 58(5):459-469. PubMed ID: 36847918
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract][Full Text] [Related]
27. Incidence and survival in late liver metastases of colorectal cancer.
Landreau P; Drouillard A; Launoy G; Ortega-Deballon P; Jooste V; Lepage C; Faivre J; Facy O; Bouvier AM
J Gastroenterol Hepatol; 2015 Jan; 30(1):82-5. PubMed ID: 25088563
[TBL] [Abstract][Full Text] [Related]
28. Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
Veld JV; Wisselink DD; Amelung FJ; Consten ECJ; de Wilt JHW; de Hingh I; Bemelman WA; van Hooft JE; Tanis PJ;
Ann Surg Oncol; 2020 Aug; 27(8):2762-2773. PubMed ID: 32170481
[TBL] [Abstract][Full Text] [Related]
29. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer ovarian metastases.
Thornblade LW; Han E; Fong Y
Int J Gynecol Cancer; 2021 Aug; 31(8):1137-1144. PubMed ID: 34083378
[TBL] [Abstract][Full Text] [Related]
32. Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma.
Rose JS; Serna DS; Martin LK; Li X; Weatherby LM; Abdel-Misih S; Zhao W; Bekaii-Saab T
Cancer; 2012 Dec; 118(24):6243-52. PubMed ID: 22674181
[TBL] [Abstract][Full Text] [Related]
33. Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous?
Watanabe M; Kochi M; Fujii M; Kaiga T; Mihara Y; Funada T; Tamegai H; Shimizu H; Takayama T
Am J Clin Oncol; 2012 Oct; 35(5):407-10. PubMed ID: 21659834
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases.
Mekenkamp LJ; Koopman M; Teerenstra S; van Krieken JH; Mol L; Nagtegaal ID; Punt CJ
Br J Cancer; 2010 Jul; 103(2):159-64. PubMed ID: 20551951
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer liver metastases - understanding the differences in the management of synchronous and metachronous disease.
Tan EK; Ooi LL
Ann Acad Med Singap; 2010 Sep; 39(9):719-15. PubMed ID: 20957308
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN
Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer.
Yoon SN; Oh ST; Lim SB; Kim TW; Kim JH; Yu CS; Kim JC
World J Surg; 2010 Sep; 34(9):2168-76. PubMed ID: 20532772
[TBL] [Abstract][Full Text] [Related]
38. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
Suthananthan AE; Bhandari M; Platell C
ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
[TBL] [Abstract][Full Text] [Related]
39. Resection of liver metastases in colorectal cancer--competitive analysis of treatment results in synchronous versus metachronous metastases.
Schlag P; Hohenberger P; Herfarth C
Eur J Surg Oncol; 1990 Aug; 16(4):360-5. PubMed ID: 2379594
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
